Randomised Phase 1b/2 trial of tepotinib vs sorafenib in Asian patients with advanced hepatocellular carcinoma with MET overexpression.

Baek-Yeol Ryoo Ann-Lii ChengZhenggang RenTae-You KimHongming PanKun-Ming RauHye Jin ChoiJoong-Won ParkJee Hyun KimChia Jui YenHo Yeong LimDongli ZhouJosef StraubJuergen ScheeleKarin BerghoffShukui Qin

Published in: British journal of cancer (2021)

ClinicalTrials.gov NCT01988493.

Keyphrases

study protocol
clinical trial
open label
phase iii
phase ii
double blind
placebo controlled
cell proliferation
randomized controlled trial
tyrosine kinase
transcription factor